222 related articles for article (PubMed ID: 29405696)
41. Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity.
Sepúlveda CS; García CC; Levingston Macleod JM; López N; Damonte EB
PLoS One; 2013; 8(11):e81251. PubMed ID: 24278404
[TBL] [Abstract][Full Text] [Related]
42. A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.
Ziegler CM; Eisenhauer P; Kelly JA; Dang LN; Beganovic V; Bruce EA; King BR; Shirley DJ; Weir ME; Ballif BA; Botten J
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187543
[TBL] [Abstract][Full Text] [Related]
43. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).
King BR; Hershkowitz D; Eisenhauer PL; Weir ME; Ziegler CM; Russo J; Bruce EA; Ballif BA; Botten J
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539447
[TBL] [Abstract][Full Text] [Related]
44. Current drug discovery strategies against arenavirus infections.
Pasquato A; Burri DJ; Kunz S
Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1297-309. PubMed ID: 23241187
[TBL] [Abstract][Full Text] [Related]
45. Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.
Warner NL; Jokinen JD; Beier JI; Sokoloski KJ; Lukashevich IS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29439402
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.
Asper M; Sternsdorf T; Hass M; Drosten C; Rhode A; Schmitz H; Günther S
J Virol; 2004 Mar; 78(6):3162-9. PubMed ID: 14990737
[TBL] [Abstract][Full Text] [Related]
47. Arenavirus reverse genetics for vaccine development.
Ortiz-Riaño E; Cheng BYH; Carlos de la Torre J; Martínez-Sobrido L
J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194
[TBL] [Abstract][Full Text] [Related]
48. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
[TBL] [Abstract][Full Text] [Related]
49. Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses.
Martínez-Sobrido L; de la Torre JC
Viruses; 2016 Jul; 8(7):. PubMed ID: 27447662
[TBL] [Abstract][Full Text] [Related]
50. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
Cheng BYH; Nogales A; de la Torre JC; Martínez-Sobrido L
Virology; 2017 Jan; 501():35-46. PubMed ID: 27855284
[TBL] [Abstract][Full Text] [Related]
51. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
[TBL] [Abstract][Full Text] [Related]
52. An Antiviral Drug Screening Platform with a FRET Biosensor for Measurement of Arenavirus Z Assembly.
Mizutani T; Ohba Y; Mizuta S; Yasuda J; Urata S
Cell Struct Funct; 2020 Dec; 45(2):155-163. PubMed ID: 33191384
[TBL] [Abstract][Full Text] [Related]
53. Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus.
Wang Q; Xin Q; Shang W; Wan W; Xiao G; Zhang LK
Viruses; 2021 May; 13(6):. PubMed ID: 34070281
[TBL] [Abstract][Full Text] [Related]
54. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
Iwasaki M; Minder P; Caì Y; Kuhn JH; Yates JR; Torbett BE; de la Torre JC
PLoS Pathog; 2018 Feb; 14(2):e1006892. PubMed ID: 29462184
[TBL] [Abstract][Full Text] [Related]
55. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.
Emonet SF; Garidou L; McGavern DB; de la Torre JC
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3473-8. PubMed ID: 19208813
[TBL] [Abstract][Full Text] [Related]
56. The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle.
Mizuma K; Takashima A; Cubitt B; de la Torre JC; Iwasaki M
Virology; 2022 Nov; 576():83-95. PubMed ID: 36183499
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.
Lee AM; Rojek JM; Gundersen A; Ströher U; Juteau JM; Vaillant A; Kunz S
Virology; 2008 Mar; 372(1):107-17. PubMed ID: 18022208
[TBL] [Abstract][Full Text] [Related]
58. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
59. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.
Xing J; Ly H; Liang Y
J Virol; 2015 Mar; 89(5):2944-55. PubMed ID: 25552708
[TBL] [Abstract][Full Text] [Related]
60. Single nucleoprotein residue modulates arenavirus replication complex formation.
Knopp KA; Ngo T; Gershon PD; Buchmeier MJ
mBio; 2015 Apr; 6(3):e00524-15. PubMed ID: 25922393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
